BIO
$377.71-0.48%
as of close, Sep 30, 2026
☾ AH $377.71 -0.48%
Bio-Rad Laboratories Inc.Stock · IndustrialsRussell 3000 0.008%Russell 1000 0.008%US Stock Market 0.007%
BIO financial statements
The full income statement, balance sheet, and cash-flow statement for Bio-Rad Laboratories Inc. (BIO), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 27.9M2024-09 28.0M2024-12 28.0M2025-03 27.2M2025-06 27.1M2025-09 27.0M2025-12 27.0M2026-03 26.8M2026-06 26.7M-4.1% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 2.58B+0.7% | 2.57B-3.9% | 2.67B-4.7% | 2.80B-4.1% | 2.92B+14.8% | |
| 1.34B-2.8% | 1.38B-3.4% | 1.43B-9.0% | 1.57B-4.3% | 1.64B+13.9% | ||
| Cost of revenue | 1.24B+4.7% | 1.19B-4.6% | 1.24B+0.8% | 1.23B-3.9% | 1.28B+16.0% | |
| Research & development | 276M-6.9% | 296M+19.6% | 247M-3.7% | 257M-1.4% | 261M+19.7% | |
| Selling, general & administrative | 844M+3.7% | 814M-3.3% | 842M+1.7% | 828M-5.6% | 877M+9.8% | |
| Restructuring | — | — | — | 0.00-100.0% | 75.6M | |
| Amortization of intangibles | 23.8M+12.3% | 21.2M-10.9% | 23.8M-4.4% | 24.9M-12.3% | 28.4M+3.3% | |
| Provision for credit losses | 1.40M | 0.00 | 0.00-100.0% | 7.50M | 0.00 | |
| Operating income | 47.2M-82.5% | 269M-20.4% | 338M-30.0% | 483M-3.5% | 500M+18.8% | |
| Interest expense | 49.0M+0.2% | 48.9M-1.0% | 49.4M+29.7% | 38.1M+2356.5% | 1.55M-92.9% | |
| Other non-operating income | 90.3M+0.0% | 90.3M-15.2% | 107M+138.3% | 44.7M+66.9% | 26.8M+9.3% | |
| Gain (loss) on equity securities | 900M+133.9% | -2.66B-112.2% | -1.25B+75.9% | -5.19B | — | |
| Pre-tax income | 996M+142.5% | -2.34B-175.6% | -850M+81.9% | -4.70B-186.3% | 5.45B+10.8% | |
| Income tax | 236M+147.3% | -498M-134.2% | -213M+80.2% | -1.08B-190.1% | 1.19B+8.2% | |
| Net income | 760M+141.2% | -1.84B-189.4% | -637M+82.4% | -3.63B-185.3% | 4.25B+11.5% | |
| $27.85+142.6% | -$65.36-199.5% | -$21.82+82.1% | -$121.79-186.5% | $140.83+11.4% | ||
| EPS (basic) | $27.87+142.6% | -$65.36-199.5% | -$21.82+82.1% | -$121.79-185.4% | $142.61+11.3% | |
| Weighted-avg shares (basic) | 27.3M-3.4% | 28.2M-3.4% | 29.2M-1.9% | 29.8M-0.2% | 29.8M+0.2% | |
| Weighted-avg shares (diluted) | 27.3M-3.3% | 28.2M-3.4% | 29.2M-1.9% | 29.8M-1.4% | 30.2M+0.2% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 2.91B-4.1% | 3.03B-0.6% | 3.05B-3.5% | 3.16B+58.7% | 1.99B-7.0% | ||
| Cash & equivalents | 530M+8.5% | 488M+20.9% | 404M-7.0% | 434M-7.8% | 471M-28.9% | |
| Short-term investments | 1.01B-14.1% | 1.18B-2.2% | 1.20B-11.3% | 1.36B+239.8% | 399M+21.3% | |
| Accounts receivable | 461M+1.8% | 453M-7.5% | 489M-1.1% | 495M+16.8% | 424M+1.0% | |
| Inventory | 741M-2.5% | 760M-2.6% | 781M+8.5% | 719M+25.7% | 572M-8.0% | |
| Prepaid expenses | 137M+11.3% | 123M-12.4% | 140M+12.7% | 124M+13.8% | 109M+20.4% | |
| Other current assets | 27.7M-9.8% | 30.7M+17.6% | 26.1M+10.6% | 23.6M+134.0% | 10.1M-7.1% | |
| 10.6B+12.9% | 9.36B-23.9% | 12.3B-8.9% | 13.5B-24.1% | 17.8B+37.2% | ||
| Property, plant & equipment | 540M+2.2% | 528M-0.2% | 529M+6.1% | 499M-2.5% | 512M+4.1% | |
| Operating lease right-of-use | 170M+5.9% | 161M-17.6% | 195M+7.6% | 181M-11.6% | 205M+1.3% | |
| Goodwill | 580M+41.2% | 411M-0.7% | 414M+1.7% | 407M+17.0% | 347M+19.0% | |
| Intangible assets | 174M-40.6% | 294M-8.4% | 321M-3.5% | 332M+30.8% | 254M+27.3% | |
| Long-term investments | 6.10B+26.1% | 4.84B-37.1% | 7.70B-12.8% | 8.83B-38.6% | 14.4B+50.5% | |
| Other non-current assets | 103M+0.8% | 102M+7.4% | 94.9M+0.3% | 94.6M-9.2% | 104M+20.1% | |
| 517M+10.5% | 468M-10.5% | 523M-8.1% | 569M-16.5% | 681M+7.8% | ||
| Accounts payable | 129M+5.5% | 122M-15.4% | 145M+7.1% | 135M-4.9% | 142M+1.8% | |
| Deferred revenue | 48.9M+2.3% | 47.8M-6.5% | 51.1M-2.1% | 52.2M+2.7% | 50.9M+19.7% | |
| Current lease liability | 36.1M-13.4% | 41.7M+3.2% | 40.4M+11.2% | 36.3M-0.3% | 36.4M-0.2% | |
| Other current liabilities | 142M-3.7% | 147M-8.9% | 162M-4.7% | 170M+32.6% | 128M-2.4% | |
| Finance lease liability (current) | 500K+25.0% | 400K-20.0% | 500K+0.0% | 500K+0.0% | 500K+0.0% | |
| 3.12B+11.7% | 2.79B-21.4% | 3.56B-8.5% | 3.89B-5.5% | 4.11B+33.0% | ||
| Long-term debt | 1.20B+0.1% | 1.20B+0.1% | 1.20B+0.1% | 1.20B+11291.5% | 10.5M-14.2% | |
| Non-current lease liability | 146M+10.9% | 131M-20.6% | 166M+7.7% | 154M-12.7% | 176M+0.5% | |
| Operating lease liability (total) | 182M+5.0% | 173M-15.9% | 206M+8.4% | 190M-10.6% | 212M+0.3% | |
| Finance lease liability (total) | 9.20M-4.2% | 9.60M-5.0% | 10.1M-4.7% | 10.6M-3.6% | 11.0M-4.3% | |
| Finance lease liability | 8.70M-5.4% | 9.20M-4.2% | 9.60M-5.0% | 10.1M-3.8% | 10.5M-4.5% | |
| Deferred tax liabilities | 1.06B+29.5% | 818M-44.6% | 1.48B-16.7% | 1.77B-42.2% | 3.06B+47.6% | |
| Other non-current liabilities | 199M+12.4% | 177M-9.1% | 195M-0.5% | 196M+7.5% | 182M-7.5% | |
| 7.45B+13.5% | 6.57B-24.8% | 8.74B-9.1% | 9.62B-29.7% | 13.7B+38.4% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Additional paid-in capital | 476M+2.8% | 463M+3.1% | 449M+0.4% | 447M+1.3% | 442M+2.9% | |
| Retained earnings | 8.18B+10.2% | 7.42B-19.9% | 9.26B-6.4% | 9.90B-26.8% | 13.5B+45.9% | |
| Treasury stock | 1.01B+30.8% | 772M+22.1% | 633M+140.0% | 264M | — | |
| Accumulated other comprehensive income | -189M+64.9% | -538M-60.2% | -336M+28.0% | -467M-165.9% | -176M-162.2% | |
| Total liabilities & equity | 10.6B+12.9% | 9.36B-23.9% | 12.3B-8.9% | 13.5B-24.1% | 17.8B+37.2% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 532M+16.9% | 455M+21.4% | 375M+92.8% | 194M-71.0% | 669M+14.4% | ||
| Depreciation & amortization | 165M+9.1% | 152M+3.9% | 146M+6.3% | 137M-0.2% | 138M-0.7% | |
| Intangible amortization | 23.8M+12.3% | 21.2M-10.9% | 23.8M-4.4% | 24.9M-12.3% | 28.4M+3.3% | |
| Share-based compensation | 58.0M-6.9% | 62.3M+1.6% | 61.3M+0.7% | 60.9M+18.9% | 51.2M+23.1% | |
| Deferred income taxes | 171M+127.2% | -627M-94.3% | -323M+74.0% | -1.24B-214.4% | 1.08B+10.5% | |
| Change in receivables | -19.6M-21.0% | -16.2M-42.1% | -11.4M-113.0% | 87.4M+328.4% | 20.4M+36.0% | |
| Change in inventory | -68.9M-710.6% | -8.50M-118.4% | 46.3M-70.8% | 159M+444.5% | -46.1M-188.5% | |
| -190M-18.4% | -160M-893.1% | 20.2M+101.7% | -1.21B-51.4% | -797M-1040.8% | ||
| Capital expenditure | 158M-4.8% | 166M+5.7% | 157M+38.9% | 113M-15.7% | 134M+23.2% | |
| Free cash flow | 375M+29.4% | 290M+32.7% | 218M+167.4% | 81.6M-84.8% | 536M+12.4% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Purchases of investments | 669M-47.6% | 1.28B+85.3% | 689M-66.6% | 2.06B+141.9% | 852M+242.8% | |
| Sales/maturities of investments | 62.0M-68.9% | 199M-44.8% | 361M+1.0% | 358M+4.8% | 341M+22.6% | |
| Proceeds from sale of PP&E | 100K+0.0% | 100K-50.0% | 200K+0.0% | 200K+284.6% | 52.0K-25.7% | |
| Other investing activities | — | 0.00 | 0.00-100.0% | 1.50M | 0.00+100.0% | |
| -283M-29.4% | -219M+48.6% | -426M-143.7% | 974M+1856.5% | -55.4M+89.4% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00-100.0% | 1.19B | 0.00 | |
| Long-term debt repaid | 500K+25.0% | 400K-20.0% | 500K+0.0% | 500K-83.4% | 3.02M-99.3% | |
| Common stock issued | 0.00 | 0.00 | 0.00-100.0% | 3.40M+283.8% | -1.85M-125.5% | |
| Common stock repurchased | 296M+45.1% | 204M-52.5% | 429M+98.7% | 216M+331.4% | 50.0M-50.0% | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FX effect on cash | — | — | — | — | -12.6M-201.7% | |
| Net change in cash | 42.4M-50.4% | 85.4M+383.7% | -30.1M+17.8% | -36.6M+81.3% | -196M-4490.3% | |
| Interest paid | 46.6M+0.2% | 46.5M-2.1% | 47.5M+94.7% | 24.4M+984.0% | 2.25M-89.6% | |
| Income taxes paid | 61.6M-38.0% | 99.4M-23.3% | 130M-18.1% | 158M+17.5% | 135M+106.4% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 8.18B-11.1% | 9.20B-2.2% | 9.41B-25.0% | 12.5B-44.5% | 22.6B+30.0% | |
| P/E | 10.8× | — | — | — | 5.3×+16.5% | |
| P/S | 3.2×-11.7% | 3.6×+3.6% | 3.5×-22.6% | 4.5×-42.2% | 7.7×+13.2% | |
| P/B | 1.1×-21.7% | 1.4×+25.3% | 1.1×-24.4% | 1.5×-10.4% | 1.7×-6.1% | |
| P/FCF | 21.8×-31.3% | 31.8×-24.3% | 42.0×-49.3% | 82.8×+96.2% | 42.2×+15.6% | |
| Earnings yield | 9.3% | — | — | — | 18.8%-14.2% | |
| FCF yield | 4.6%+45.5% | 3.1%+32.1% | 2.4%+97.3% | 1.2%-49.0% | 2.4%-13.5% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: BIO’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all BIO filings on SEC EDGAR → Not investment advice.